Effect of sodium benzoate in the treatment of atypical nonketotic hyperglycinaemia

Journal of Inherited Metabolic Disease

Volumn 23, Issue 1, 2000, Pages 22-26

  Neuberger, J M ^a,c   Schweitzer, S ^d   Rolland, M O ^b   Burghard, R ^a  

^a Children's Hospital   (Germany)

^b HÔPITAL DEBROUSSE   (France)

^c Private Bag X2031   (South Africa)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; DEXTROMETHORPHAN; GLYCINE CLEAVAGE SYSTEM;

ARTICLE; BEHAVIOR DISORDER; CASE REPORT; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HYPERGLYCINEMIA; HYPSARRHYTHMIA; INFANT; KETOACIDOSIS; LIVER; MENTAL DEFICIENCY; MUSCLE HYPOTONIA; PSYCHOMOTOR DISORDER; SEIZURE; WALKING;

ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYPERGLYCINEMIA, NONKETOTIC; INFANT; SODIUM BENZOATE;

EID: 0033985498     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005642728513     Document Type: Article

References (16)

1. Alemzadeh R, Gammeltoft K, Matteson K (1996) Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia. Pediatrics 97: 924-926.
2. Barshop BA, Breuer J, Holm J, Leslie J, Nyhan WL (1989) Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinemia or hyperammonaemia. J Inher Metab Dis 12: 72-79.
3. Benveniste M, Mayer ML (1991) Kinetic analysis of antagonist action at N-methyl-D-aspartatic acid receptors. Two bindings sites each for glutamate and glycine. Biophys J 59: 560-573.
4. Boneh A, Degani Y, Harari M (1996) Prognostic clues and outcome of early treatment of nonketotic hyperglycinemia. Pediatr Neurol 15: 137-141.
5. Christodoulou J, Kure S, Hayasaka K, Clarke JT (1993) Atypical nonketotic hyperglycinemia confirmed by assay of the glycine cleavage system in lymphoblasts. J Pediatr 123: 100-102.
6. Flannery DB, Pellock J, Bousounis D, Hunt P, Nance C, Wolf B (1983) Nonketotic hyperglycinemia in two retarded adults: a mild form of infantile nonketotic hyperglycinaemia. Neurology 33: 1064-1066.
7. Frazier DM, Summer GK, Chamberlin HR (1978) Hyperglycinuria and hyperglycinemia in two siblings with mild developmental delay. Am J Dis Child 132: 777-781.
8. Hamosh A, McDonald JW, Valle D, Francomano CA (1990) Combination benzoate and dextromethorphan therapy for nonketotic hyperglycinemia. Am J Hum Genet 47: A157.
9. Hamosh A, McDonald JW, Valle D, Francomano CA, Niedermeyer E, Johnston MV (1992) Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 121: 131-135.
10. Hamosh A, Johnston MV, Valle D (1995) Nonketotic hyperglycinemia. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1337-1348.
11. Hamosh A, Maher JF, Bellus GA, Rasmussen SA, Johnston MV (1998) Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 132: 709-713.
12. Hayasaka K, Tada K, Fueki N, et al (1987) Nonketotic hyperglycinemia: analyses of glycine cleavage system in typical and atypical cases. J Pediatr 110: 873-877.
13. Holmgren G, Blomquist HK (1997) Nonketotic hyperglycinemia in two sibs with mild psycho-neurological symptoms. Neuropaediatrie 8: 67-69.
14. Schmitt B, Steinmann B, Gitzelmann R, Thun-Hohenstein L, Mascher H, Dumermuth G (1993) Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology 43: 421-424.
15. Singer HS, Valle D, Hayasaka K, Tada K (1989) Nonketotic hyperglycinemia: studies in an atypical variant. Neurology 39: 286-288.
16. Wolff JA, Kulovich S, Yu-Al, Qiao CN, Nyhan WL (1986) The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia. Am J Dis Child 140: 596-602.